Company intelligence / Profile preview

Ark Animal Health

Overland Park, Kansas, United States

Ownership: Private
Development stage: Other

Overview

Ark Animal Health was a development-stage veterinary pharmaceutical company based in Overland Park, Kansas, specializing in the creation of innovative therapeutics for companion animals. The company focused on identifying unmet needs in the pet health market, particularly in the areas of orthopedics and pain management. In December 2013, Ark Animal Health was acquired by Parnell Pharmaceuticals, an Australian veterinary health firm, to serve as its primary US development and regulatory hub. This acquisition integrated Ark's expertise in FDA Center for Veterinary Medicine (CVM) pathways, facilitating the clinical advancement of the lead canine osteoarthritis drug, Zydax.

Therapeutic areas: NeurologyImmunologyRheumatology
Modalities: Small molecule
Industry: Veterinary

Beyond the preview

Go deeper on Ark Animal Health.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Ark Animal Health.

Explore the full profile